XLON
CLBX
Market cap10mUSD
Oct 28, Last price
2.40GBP
Name
Angle PLC
Chart & Performance
P/E
—
P/S
2.70
EPS
—
Div Yield, %
—
Shrs. gr., 5y
12.46%
Rev. gr., 5y
26.85%
Revenues
3m
+30.92%
Net income
-14m
L-29.34%
CFO
-13m
L-6.99%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
ANGLE plc is a medical diagnostics firm that specializes in developing advanced products for cancer detection. Its flagship offering is the Parsortix cell separation system, engineered to isolate and collect circulating tumor cells (CTCs) from the bloodstream of patients with metastatic breast cancer. The company also provides the HyCEAD multiplex analysis system, which enables both routine and targeted analysis of DNA, RNA, or protein biomarkers. Founded in 1994, ANGLE plc is headquartered in Guildford, United Kingdom.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2019‑04 | 2018‑04 | 2017‑04 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||